Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 520 entries
View as:

Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03514017 Org: User:
Start: 05/31/19 End: 05/16/23 Due: 05/16/24

Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00609765 Org: User:
Start: 08/31/07 End: 03/31/08 Due: 03/31/09

Dendritic Cell Vaccination During Lymphoid Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT00313508 Org: User:
Start: 02/28/06 End: 03/31/12 Due: 03/31/13

Aim 1: App for Reducing Cravings to Smoke

Phase: N/A Priority: Normal
NCT ID: NCT06923033 Org: User:
Start: 10/09/23 End: 11/02/23 Due: 11/02/24

Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health

Phase: N/A Priority: Normal
NCT ID: NCT04464668 Org: User:
Start: 06/25/20 End: 01/31/26 Due: 01/31/27

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03043599 Org: User:
Start: 02/13/17 End: 11/16/23 Due: 11/16/24

TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03686488 Org: User:
Start: 12/20/18 End: 05/31/24 Due: 05/31/25

Modifying Diet to Improve Gut Microbiome

Phase: N/A Priority: Normal
NCT ID: NCT03924778 Org: User:
Start: 07/31/25 End: 06/30/26 Due: 06/30/27

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT06350318 Org: User:
Start: 04/19/24 End: 03/31/29 Due: 03/31/30

Erlotinib Study for Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00977548 Org: User:
Start: 09/30/09 End: 06/30/12 Due: 06/30/13

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02155088 Org: User:
Start: 10/30/14 End: 01/31/20 Due: 01/31/21

Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02638090 Org: User:
Start: 03/22/16 End: 01/21/26 Due: 01/21/27

Outreach Core Activities

Phase: N/A Priority: Normal
NCT ID: NCT05832177 Org: User:
Start: 03/22/23 End: 07/31/28 Due: 07/31/29

Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center

Phase: N/A Priority: Normal
NCT ID: NCT05065944 Org: User:
Start: 11/16/21 End: 08/09/24 Due: 08/09/25

Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab

Phase: N/A Priority: Normal
NCT ID: NCT05325632 Org: User:
Start: 10/28/21 End: 10/31/26 Due: 10/31/27

CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML

Phase: N/A Priority: Normal
NCT ID: NCT05558124 Org: User:
Start: 02/16/23 End: 11/30/25 Due: 11/30/26

Bicarbonate for Tumor Related Pain

Phase: N/A Priority: Normal
NCT ID: NCT01350583 Org: User:
Start: 08/31/10 End: 05/31/12 Due: 05/31/13

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

Phase: N/A Priority: Normal
NCT ID: NCT00612677 Org: User:
Start: 06/30/07 End: 01/31/08 Due: 01/31/09

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT04974619 Org: User:
Start: 07/23/21 End: 08/30/22 Due: 08/30/23

Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01042535 Org: User:
Start: 12/28/09 End: 02/27/18 Due: 02/27/19

Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator

Phase: N/A Priority: Normal
NCT ID: NCT04268979 Org: User:
Start: 02/13/20 End: 07/31/25 Due: 07/31/26

A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT01859026 Org: User:
Start: 12/30/13 End: 08/22/19 Due: 08/22/20

Automated Video-Assisted Smoking Treatment for People Living With HIV

Phase: N/A Priority: Normal
NCT ID: NCT05014282 Org: User:
Start: 12/15/21 End: 09/23/26 Due: 09/23/27

Clinical Trials Outreach & Education

Phase: N/A Priority: Normal
NCT ID: NCT05064423 Org: User:
Start: 06/15/21 End: 03/23/22 Due: 03/23/23

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

Phase: N/A Priority: Normal
NCT ID: NCT04588545 Org: User:
Start: 12/10/20 End: 07/29/25 Due: 07/29/26